Immune Effect of Dexmedetomidine in Patients Undergoing to Spinal Fusion
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Alpha-agonist in anesthesia display immunomodulatory effect in addition to antiadrenergic
control. This effect of the immune system can be a key to a better perioperative safety and
quality.
The association of dexmedetomidine at general anesthesia adds up organic protection and
inflammatory control to a surgery trauma owing to antinociception and immunomodulatory
effect.
The aim this study is evaluate if the association of dexmedetomidine at general anesthesia
standing effective immunomodulatory control to trauma and improve changes at outcomes in
patients undergoing to spinal fusion.